168 related articles for article (PubMed ID: 19895612)
1. An increased frequency of 13q deletions detected by fluorescence in situ hybridization and its impact on survival in children and adolescents with Burkitt lymphoma: results from the Children's Oncology Group study CCG-5961.
Nelson M; Perkins SL; Dave BJ; Coccia PF; Bridge JA; Lyden ER; Heerema NA; Lones MA; Harrison L; Cairo MS; Sanger WG
Br J Haematol; 2010 Feb; 148(4):600-10. PubMed ID: 19895612
[TBL] [Abstract][Full Text] [Related]
2. Fish evaluation of additional cytogenetic aberrations and hyperdiploidy in childhood Burkitt lymphoma.
Avgerinou G; Stefanaki K; Liapis K; Kostopoulos IV; Kossiva L; Tzoumaka-Bakoula C; Pavlidis D; Filippidou M; Katsibardi K; Ampatzidou M; Kattamis A; Polychronopoulou S; Mantzourani M; Papadhimitriou SI
Leuk Lymphoma; 2022 Mar; 63(3):551-561. PubMed ID: 34727830
[TBL] [Abstract][Full Text] [Related]
3. Patterns of genomic aberrations suggest that Burkitt lymphomas with complex karyotype are distinct from other aggressive B-cell lymphomas with MYC rearrangement.
Havelange V; Ameye G; Théate I; Callet-Bauchu E; Mugneret F; Michaux L; Dastugue N; Penther D; Barin C; Collonge-Rame MA; Baranger L; Terré C; Nadal N; Lippert E; Laï JL; Cabrol C; Tigaud I; Herens C; Hagemeijer A; Raphael M; Libouton JM; Poirel HA;
Genes Chromosomes Cancer; 2013 Jan; 52(1):81-92. PubMed ID: 23012230
[TBL] [Abstract][Full Text] [Related]
4. Chromosome abnormalities may correlate with prognosis in Burkitt/Burkitt-like lymphomas of children and adolescents: a report from Children's Cancer Group Study CCG-E08.
Lones MA; Sanger WG; Le Beau MM; Heerema NA; Sposto R; Perkins SL; Buckley J; Kadin ME; Kjeldsberg CR; Meadows A; Siegel S; Finlay J; Bergeron S; Cairo MS;
J Pediatr Hematol Oncol; 2004 Mar; 26(3):169-78. PubMed ID: 15125609
[TBL] [Abstract][Full Text] [Related]
5. B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma.
Snuderl M; Kolman OK; Chen YB; Hsu JJ; Ackerman AM; Dal Cin P; Ferry JA; Harris NL; Hasserjian RP; Zukerberg LR; Abramson JS; Hochberg EP; Lee H; Lee AI; Toomey CE; Sohani AR
Am J Surg Pathol; 2010 Mar; 34(3):327-40. PubMed ID: 20118770
[TBL] [Abstract][Full Text] [Related]
6. Interstitial 13q14 deletions detected in the karyotype and translocations with concomitant deletion at 13q14 in chronic lymphocytic leukemia: different genetic mechanisms but equivalent poorer clinical outcome.
Puiggros A; Venturas M; Salido M; Blanco G; Fernandez-Rodriguez C; Collado R; Valiente A; Ruiz-Xivillé N; Carrió A; Ortuño FJ; Luño E; Calasanz MJ; Ardanaz MT; Piñán MÁ; Talavera E; González MT; Ortega M; Marugán I; Ferrer A; Gimeno E; Bellosillo B; Delgado J; Hernández JÁ; Hernández-Rivas JM; Espinet B; ;
Genes Chromosomes Cancer; 2014 Sep; 53(9):788-97. PubMed ID: 24915757
[TBL] [Abstract][Full Text] [Related]
7. Submicroscopic genomic imbalances in Burkitt lymphomas/leukemias: association with age and further evidence that 8q24/MYC translocations are not sufficient for leukemogenesis.
Lundin C; Hjorth L; Behrendtz M; Ehinger M; Biloglav A; Johansson B
Genes Chromosomes Cancer; 2013 Apr; 52(4):370-7. PubMed ID: 23225516
[TBL] [Abstract][Full Text] [Related]
8. Burkitt lymphoma (BL): reclassification of 39 lymphomas diagnosed as BL or Burkitt-like lymphoma in the past based on immunohistochemistry and fluorescence in situ hybridization.
Kodet R; Mrhalová M; Stejskalová E; Kabícková E
Cesk Patol; 2011 Jul; 47(3):106-14. PubMed ID: 21887927
[TBL] [Abstract][Full Text] [Related]
9. The effects of DLEU1 gene expression in Burkitt lymphoma (BL): potential mechanism of chemoimmunotherapy resistance in BL.
Lee S; Luo W; Shah T; Yin C; O'Connell T; Chung TH; Perkins SL; Miles RR; Ayello J; Morris E; Harrison L; van de Ven C; Cairo MS
Oncotarget; 2017 Apr; 8(17):27839-27853. PubMed ID: 28427156
[TBL] [Abstract][Full Text] [Related]
10. Conventional and molecular cytogenetic characterization of Burkitt lymphoma with bone marrow involvement in Brazilian children and adolescents.
De Souza MT; Hassan R; Liehr T; Marques-Salles TJ; Boulhosa AM; Abdelhay E; Ribeiro RC; Silva ML
Pediatr Blood Cancer; 2014 Aug; 61(8):1422-6. PubMed ID: 24668946
[TBL] [Abstract][Full Text] [Related]
11. Specific cytogenetic abnormalities are associated with a significantly inferior outcome in children and adolescents with mature B-cell non-Hodgkin's lymphoma: results of the FAB/LMB 96 international study.
Poirel HA; Cairo MS; Heerema NA; Swansbury J; Aupérin A; Launay E; Sanger WG; Talley P; Perkins SL; Raphaël M; McCarthy K; Sposto R; Gerrard M; Bernheim A; Patte C;
Leukemia; 2009 Feb; 23(2):323-31. PubMed ID: 19020548
[TBL] [Abstract][Full Text] [Related]
12. Secondary abnormalities involving 1q or 13q and poor outcome in high stage Burkitt leukemia/lymphoma cases with 8q24 rearrangement at diagnosis.
de Souza MT; Mkrtchyan H; Hassan R; Ney-Garcia DR; de Azevedo AMB; da Costa ES; de Figueiredo AF; Liehr T; Abdelhay E; Silva MLM
Int J Hematol; 2011 Feb; 93(2):232-236. PubMed ID: 21207210
[TBL] [Abstract][Full Text] [Related]
13. Molecular cytogenetic aberrations in patients with multiple myeloma studied by interphase fluorescence in situ hybridization.
Chen L; Li J; Xu W; Qiu H; Zhu Y; Zhang Y; Duan L; Qian S; Lu H
Exp Oncol; 2007 Jun; 29(2):116-20. PubMed ID: 17704743
[TBL] [Abstract][Full Text] [Related]
14. Interphase fluorescence in situ hybridization for detection of 8q24/MYC breakpoints on routine histologic sections: validation in Burkitt lymphomas from three geographic regions.
Haralambieva E; Schuuring E; Rosati S; van Noesel C; Jansen P; Appel I; Guikema J; Wabinga H; Bleggi-Torres LF; Lam K; van den Berg E; Mellink C; van Zelderen-Bhola S; Kluin P
Genes Chromosomes Cancer; 2004 May; 40(1):10-8. PubMed ID: 15034863
[TBL] [Abstract][Full Text] [Related]
15. Secondary Burkitt lymphoma in a retinoblastoma patient with 13q deletion syndrome.
Hongeng S; Parapakpenjun S; Pakakasama S; Rerkamnuaychoke B; Pornkul R
Pediatr Blood Cancer; 2006 Apr; 46(4):524-6. PubMed ID: 15926151
[TBL] [Abstract][Full Text] [Related]
16. Deletions of chromosome 13 in multiple myeloma identified by interphase FISH usually denote large deletions of the q arm or monosomy.
Fonseca R; Oken MM; Harrington D; Bailey RJ; Van Wier SA; Henderson KJ; Kay NE; Van Ness B; Greipp PR; Dewald GW
Leukemia; 2001 Jun; 15(6):981-6. PubMed ID: 11417487
[TBL] [Abstract][Full Text] [Related]
17. Predictive role of interphase cytogenetics for survival of patients with multiple myeloma.
Königsberg R; Zojer N; Ackermann J; Krömer E; Kittler H; Fritz E; Kaufmann H; Nösslinger T; Riedl L; Gisslinger H; Jäger U; Simonitsch I; Heinz R; Ludwig H; Huber H; Drach J
J Clin Oncol; 2000 Feb; 18(4):804-12. PubMed ID: 10673522
[TBL] [Abstract][Full Text] [Related]
18. The prognostic significance of 13q deletions of different sizes in patients with B-cell chronic lymphoproliferative disorders: a retrospective study.
Yi S; Li H; Li Z; Xiong W; Liu H; Liu W; Lv R; Yu Z; Zou D; Xu Y; An G; Qiu L
Int J Hematol; 2017 Sep; 106(3):418-425. PubMed ID: 28439775
[TBL] [Abstract][Full Text] [Related]
19. Cytogenetic and molecular analysis of 6q deletions in Burkitt's lymphoma cell lines.
Parsa NZ; Gaidano G; Mukherjee AB; Hauptschein RS; Lenoir G; Dalla-Favera R; Chaganti RS
Genes Chromosomes Cancer; 1994 Jan; 9(1):13-8. PubMed ID: 7507695
[TBL] [Abstract][Full Text] [Related]
20. 13q14 deletion size and number of deleted cells both influence prognosis in chronic lymphocytic leukemia.
Dal Bo M; Rossi FM; Rossi D; Deambrogi C; Bertoni F; Del Giudice I; Palumbo G; Nanni M; Rinaldi A; Kwee I; Tissino E; Corradini G; Gozzetti A; Cencini E; Ladetto M; Coletta AM; Luciano F; Bulian P; Pozzato G; Laurenti L; Forconi F; Di Raimondo F; Marasca R; Del Poeta G; Gaidano G; Foà R; Guarini A; Gattei V
Genes Chromosomes Cancer; 2011 Aug; 50(8):633-43. PubMed ID: 21563234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
